JUN 30, 2017 11:02 AM PDT

Study Finds Promising Treatment for Hot Flashes

WRITTEN BY: Xuan Pham

It's estimated that by 2025, around 1.1 billion of the women in the world will be diagnosed with menopause - a natural, hormonal condition that causes the menstrual cycle to cease. As a result of menopause, many women experience uncomfortable hot flashes. Now, by linking specific neuronal receptors to thermoregulation, researchers have found a drug that could potentially block this receptor and reduce hot flashes in postmenopausal women.

Image credit: Pixabay.com

Menopause typically happens in women between the ages of 45 and 55, when the ovaries stop releasing an egg every cycle. As a consequence, women can experience hormonal changes before menopause, during menopause, and even after menopause. Hot flashes - sudden waves of heat throughout the body - are common during menopause. Some women also report changes in mood, metabolism, sleep, and libido.

The search for a hot flash treatment started with Dr. Naomi Rance, a physician and research at the University of Arizona College of Medicine. After finding that some neurons in the hypothalamus got bigger in postmenopausal women, Rance had a hunch that this region of the brain might contain the key to some of the physical menopause symptoms that women experience.

Following her hunch, Rance found that the enlarged neurons respond to estrogen levels and altered body temperature. Furthermore, the hypothalamic area where these neurons were located contained neurokinin B, a neuropeptide. Rance went on to demonstrate that in rats, stimulation of neurokinin 3, a receptor for neurokinin B, led to increased body temperatures similar to a hot flash.

"That was really a sign that the reproductive axis is integrated with thermoregulation," said Rance. "The two systems are intimately integrated."  

After presenting her hunches at a conference, Rance began collaborating with Waljit Dhillo, an endocrinologist and professor at Imperial College, London. "Dhillo said that he and his colleagues heard the talk, and they realized that neurokinin 3 antagonists could be used as a treatment for hot flushes," Rance says. "He took the idea to the clinical arena very fast. The first thing he did was infuse women with neurokinin B, and found that it caused hot flashes."

The neurokinin 3 receptor agonist is known as MLE4901, and is currently being tested in a Phase 2 clinical trial in 68 women. So far, they report the drug significantly reduced weekly hot flash events by 73 percent with little major adverse effects.

While the team continues to pursue the drug as a treatment for hot flashes, they also have eyes on more detrimental health effects of hormonal changes - breast cancer.

But none of this would have happened if weren’t for basic science researchers like Rance. "People think everything you do has to be translational, but I want to emphasize that it was basic research that has driven me all the way along," said Rance. "This would not have happened without the National Institutes of Health budget for basic research. You just don't know if something is going have a clinical application when you start."

Additional sources: University of Arizona via Science Daily

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 14, 2018
Immunology
APR 14, 2018
A Vaccine for When Cancer Forms from Human Retroviruses
A vaccine to prevent leukemia and other diseases of the immune system caused by a specific viral infection is now a very real idea. A new study from Kyoto ...
MAY 24, 2018
Neuroscience
MAY 24, 2018
Can Brain Fold Patterns Predict Psychosis?
While it's a famous slogan and not meant to be taken verbatim, in neuroscience, it's often true that "Image is everything." A recent stud...
MAY 26, 2018
Clinical & Molecular DX
MAY 26, 2018
Testing for Liver Disease, Before Symptoms Appear
A diagnostic test for liver damage has been developed, one that can be used before symptoms even begin to appear....
MAY 30, 2018
Cell & Molecular Biology
MAY 30, 2018
Diagnosing Deadly Kidney Cancers Sooner
Researchers have found that deadly kidney cancers can be identified by assessing their evolutionary path, which is different for distinct types....
JUL 11, 2018
Clinical & Molecular DX
JUL 11, 2018
Faster, cheaper TB test makes diagnosis easier in rural areas
  Scientists, working with doctors and public health researchers in South Africa, have created a new tuberculosis test that makes it easier to diagnos...
SEP 05, 2018
Clinical & Molecular DX
SEP 05, 2018
Iron-based MRI Contrast Outperforms Less Safe Method
A new method for loading iron inside nanoparticles creates MRI contrast agents that work better than the mainstay gadolinium chelates, which face increased...
Loading Comments...